The new operation will be led by Klaus Rafeiner, who has technical experience in software for life science, particularly enterprise software used in biological and chemical research and
The collaboration targets the clinical activity and side-effect profile of the study drugs. The pancreatic cancer and breast cancer are the first target clinical indications under consideration. Immunovative
GSK discontinued the GSK2251052 trials due to the identification of microbiological findings of resistance in few patients in the Phase 2b trial designed to treat complicated urinary tract
The QPS Qualitix China Office will provide various knowledge-based contract research services including comprehensive clinical trial management and regulatory submission preparation The facility will also allow the company
Under the contract, for the first project, Telstar will manage the construction of a plant for the production of oral solids consisting of a four-story building of 32,000
The launch was based on the results from a 5-year longitudinal study, funded by the NIH, which demonstrated the ability of the test in detecting Alzheimer’s disease at
Under the agreement, Dow will utilize its fundamental materials design, high-throughput screening, and pilot-plant, and commercial scale-up capabilities, while Bend will use its SDD screening, formulation, scale-up, and
The phase III studies data include VIKING-3 and SAILING studies, which used dolutegravir in treatment of HIV patients who have already experienced treatment. The two studies support the
Emergent BioSolutions executive vice president Adam Havey said Emergent is pleased that PreviThrax has met all the key milestones necessary for BARDA to exercise the contract option. "We
Takeda Vaccine Business Division executive vice president Rajeev Venkayya said Takeda’s acquisition of LigoCyte will expand its vaccine business. The acquisition will help Takeda gain Norovirus vaccine candidate
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.